PD-0382: Radiation response of an improved optical CT based 3D gel sdosimeter for radiation therapy quality assurance  by Moftah, B. et al.
3rd ESTRO Forum 2015                                                                                                                                         S183 
 
 
All images were acquired at 100 cm SID using the integrating 
dosimetry mode at the maximum available dose rate: 600 
MU/min at 6 and 10 MV for both EPIDs, and 1400 MU/min at 6 
MV FFF and 2400 MU/min at 10 MV FFF for the aS1200. 
Different fields were delivered from 3×3 cm2 up to the 
maximum accommodated by the panel to verify the CAX 
signal increased with field size. Dose linearity was 
investigated by irradiating 10×10 cm2 fields from 1 to 100 MU 
and considering the signal on the CAX. Ghosting was assessed 
by delivering three 100 MU fields: a 10×10 cm2, followed 
immediately by a 20×20 cm2 then a second 10×10 cm2 and 
measuring residual signal ±7.5 cm from the CAX. The ratio of 
signals ±3 cm vertically from the CAX was calculated for 
fields > 8×8 cm2 to determine the impact of backscatter. The 
Modulation Transfer Function (MTF) was determined at each 
energy from images of an opaque angled edge. All image 
analysis was performed using IQWorks. 
A number of IMRT and VMAT plans were verified pre-
treatment using Portal Dosimetry (PD, Varian Medical 
Systems) and in vivo using Dosimetry Check (DC, Math 
Resolutions LLC). 
Results: Saturation was not evident and dose linearity was 
within ±1.0% at all energies / dose-rates for both detectors. 
Signal lag (Fig 1a) was <1.5% for the aS1000 and <0.6% for the 
aS1200. 
Differential backscatter (Fig 1b) from the aS1000 support arm 
increases with field size up to a maximum of 2.5%. On the 
aS1200 it is negligible (<0.5%) and independent of field size 
due to additional shielding material attached to the back of 
the panel. However, the increased backscatter overall results 
in marginally poorer MTF at lower spatial frequencies (Fig 
1c). 
All patient plans evaluated using PD yielded gamma pass 
rates (gamma < 1) of 100% when using criteria of 3%/3mm 
and >99.5% using criteria of 2%/2mm. Test plans with 2.5 mm 
MLC leaf errors required 2%/2mm to be detected on the 
aS1200 compared with 3%/3mm on the aS1000. This may be 
due to the higher bit depth and lower signal lag. 
IVD was successfully performed for large field, multi arc 
VMAT plans, with gamma pass rates > 90% at 5%/3mm for 
irradiated areas of side up to 26 cm at 150 cm SID. 
 
 
Conclusions: The aS1200 improves on the aS1000 as a 
dosimeter, overcoming limitations of the previous device and 
permitting more accurate measurements. 
Performance was found to be superior to the previous 
generation detector in every metric, except for a small 
reduction in MTF at low spatial frequencies which is not 
clinically significant. In particular, the impact of support arm 
backscatter is negligible and the ability to image large field 
and FFF beams allows the new EPID to be applied to a wider 
range of pre-treatment and IVD imaging scenarios. 
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Purpose/Objective: Polymer gel dosimeters are tissue 
equivalent materials fabricated from radiation sensitive 
chemicals which, upon irradiation, polymerize as a function 
of absorbed radiation dose. Gel dosimeters can uniquely 
record the radiation dose distribution in three-dimensions 
(3D). Such dose distribution can be subsequently imaged by 
MRI, optical computerized tomography (OCT), x-ray CT or 
ultrasound. We describe the fabrication and physical 
properties of a new gel with favorable characteristics for the 
3D Gel dosimetry applications when compared to the existing 
gel compositions. 
Materials and Methods: Three novel normoxic hydroxyl-
ethyl-methacrylate (HEMAGAT) gel variations were fabricated 
using formulation given in Table 3 (Fig.1). Its properties 
(absorbance and stability) were compared to three Acryl-
amid (PAGAT) polymer gels designed using formulation given 
in Table 1 (Fig.1), as well as four N-isopropyl-acryl-amide 
(NIPAMGAT) gels (Table 2, Fig.1).  
Each sample vial filled with gel was placed in a water 
phantom, and irradiated using a 6 MV photon beam from a 
Varian medical linear accelerator to various doses. Samples 
were transferred back to refrigerator and kept for 24 hours 
prior to absorption measurements.  
Absorption spectra of irradiated gel samples were measured 
in a range from 350 - 650 nm using UV/VIS 
spectrophotometer, model Lambda 850, from Perkin-Elmer, 
USA. Three samples at each absorbed dose were measured, 
but no significant differences in their characteristics were 
found during measurements. To test the post-irradiation 
stability of polymerized gels, we were sampling the gel 
response at two dose levels (6 and 15 Gy) once a day for 
seven days. 
Results: Figure 1 compares the dose response (absorbance 
sampled at 500 nm) for the three gel models studied. The 
first two gel models deviate from linear behavior at doses 
well below 20 Gy, while the novel HEMAGAT gel model 
retains its linear behavior even at doses of up to 30 Gy. The 
highest sensitivity of the new gel model was exhibited by the 
first chemical variation containing 4 w/w% of HEMA (2-
hydroxy-ethyl-methacrylate). Results demonstrated that the 
stability of novel HEMAGAT gel depend strongly on 
concentration of hydroquinone (HQ). For gel variations 
presented here (Fig.1, Table 3) results show no change (less 
than ±2%; 1σ) in the sample responses of up to seven days 
after irradiation. 
Conclusions: All three variations of the new gel composition 
described exhibit favorable linear behavior dose response in a 
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broader dose range (double) than the two existing gel 
compositions used for 3D Gel dosimetry applications. Also, 
the novel gel composition showed no apparent change in 
response with post-irradiation time. 
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Purpose/Objective: Recently, a number of studies 
investigating the difference in cell survival after irradiation 
with unflattened (FFF) compared to flattened beams (FF). 
Most of these studies were, on the one hand, performed 
under 'normal' oxygen conditions (21 %) and, on the other 
hand, dose homogeneity was often established using 
compensators or intensity modulation. The reproducibility of 
such setups has not yet been investigated. The aim of this 
study was to design a phantom capable of establishing 
hypoxic and normoxic conditions, providing a region of 
homogeneous dose distribution using static fields only and 
the possibility to precisely monitor the delivered dose to the 
cells for each experiment. 
Materials and Methods: A VersaHD (Elekta, Crawley, UK) 
linac was utilized, which was commissioned to produce 10 MV 
FF and FFF beams. Doses of 0.5, 1, 2, 4 and 6 Gy were 
delivered to HaCaT (human keratinocytes) cells from a gantry 
angel of 180° using a static 10x10 cm² field. The cells were 
grown and irradiated in chamber slides, which consist of two 
wells each with inner dimensions of 2x2 cm². Only one well 
was used for the cells, the other one was filled with culture 
medium to provide scatter material. A PMMA insert was 
manufactured to fit the chamber slide between solid water 
slabs in a depth of 10 cm. Two holes were drilled through the 
PMMA insert in order to provide gas exchange, either ambient 
air for normoxic or nitrogen for hypoxic conditions. Dose 
homogeneity and monitor units necessary to deliver the 
specified doses to the cells were assessed using EBT3 films. . 
In order to determine the reproducibility of the setup of each 
cell irradiation, a Farmer chamber TM 30006 (PTW, Freiburg, 
Germany) was positioned downstream the beam line. The 
described setup is depicted in Fig. 1a. Cell survival was 
investigated in a clonogenic assay. Based on that, α and β 
values of the cell survival curves were calculated for cells 
irradiated with FF and FFF beams. 
Results: The film measurements showed that when using the 
chamber slides it is possible to establish an isolated region 
with cells where a dose homogeneity within ± 2% can be 
achieved even in FFF mode. The Farmer chamber 
measurements revealed a reproducibility of the dose 
between the individual cell irradiations within 0.5%. Alpha 
values of 0.16 and 0.11 were determined of cells irradiated 
with FF (dose rate ~4 Gy/min) and FFF beams (dose rate ~16 
Gy/min), respectively. Both values agreed within their 
uncertainty. Beta values were 0.05 for both FF and FFF 
beams. 
 
Conclusions: An experimental setup could be established for 
reproducible cell irradiations in FF and FFF mode with 
sufficient dose homogeneity, without altering the beam itself 
or by the use of compensators or intensity modulation. 
Furthermore, this experimental setup enables simulation of 
different oxygen conditions. So far, no difference in survival 
of HaCaT cells was detected between irradiation with FFF or 
FF beams.  
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Purpose/Objective: With the aim of improving the accuracy 
and consistency of clinical dosimetry in hospitals world-wide, 
the XX Thermoluminescence Dosimetry (TLD) Postal Audit 
Program has been operating since 1969. In this study, we 
explore the dependence of the quality of clinical dosimetry in 
participating institutions on several key infrastructure 
characteristics. 
Materials and Methods: The Postal Audit Program compares 
the dose read from the mailed TLD with that stated to have 
been delivered by the Institution. Agreement to within ±5% is 
regarded as being acceptable with larger deviations 
triggering follow-up actions. Of particular interest in this 
study was the dependence of clinical dosimetry quality on i) 
age of the treatment machine, ii) 60Co vs linac, iii) number of 
machines in the participating centre, iv) elapsed time since 
the last dosimetry system calibration v) whether the audit 
was the first one or a subsequent one and vi) the dosimetry 
protocol used (a sub-set of 7182 TLDs). Quality, in this 
context, is defined as the percentage of results within the 
XX's criterion of acceptability of ±5%. Also, it is to be noted 
that the term 'clinical dosimetry' encompasses calibration of 
the institution's beam, the institution's dosimetry calculations 
and irradiation of the Postal Audit TLDs as it was clearly not 
possible to isolate these different contributors to the final 
result. 
